SAS
GNOM icon

Stelac Advisory Services’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Stelac Advisory Services’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,751
Closed -$120K – 109
2025
Q1 		$120K Buy
3,751
+755
+25% +$28.7K 0.05% 93
2024
Q4 		$116K Hold
2,996
– – 0.05% 100
2024
Q3 		$135K Hold
2,996
– – 0.05% 93
2024
Q2 		$125K Hold
2,996
– – 0.05% 97
2024
Q1 		$136K Hold
2,996
– – 0.06% 90
2023
Q4 		$139K Hold
2,996
– – 0.07% 77
2023
Q3 		$122K Hold
2,996
– – 0.07% 94
2023
Q2 		$145K Hold
2,996
– – 0.06% 137
2023
Q1 		$148K Hold
2,996
– – 0.06% 137
2022
Q4 		$152K Sell
2,996
-190
-6% -$9.8K 0.07% 133
2022
Q3 		$160K Hold
3,186
– – 0.07% 135
2022
Q2 		$156K Buy
3,186
+1,326
+71% +$67.2K 0.06% 143
2022
Q1 		$112K Buy
1,860
+97
+6% +$6.12K 0.04% 161
2021
Q4 		$140K Buy
+1,763
New +$148K 0.04% 165

Other funds holding GNOM

FTUS
Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
IA
Insight Advisors Newtown, Pennsylvania $567M AUM 25.52% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return
OCM
One Capital Management Westlake Village, California $3.6B AUM 16.02% 1-Year Est. Return

Stelac Advisory Services's GNOM Position: Q2 2025 in Review

Stelac Advisory Services sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q2 2025, closing a stake of 3,751 shares — an estimated $120K sold.

Stelac Advisory Services first reported a position in GNOM in Q4 2021 and held it in 14 quarters. The position peaked at $160K in Q3 2022. 53 funds tracked by Wall St. Rank hold GNOM as of Q2 2025.

  • Stelac Advisory Services reported no remaining Global X Genomics & Biotechnology ETF position as of Q2 2025 after selling out during the quarter.
  • Stelac Advisory Services sold 3,751 Global X Genomics & Biotechnology ETF shares in Q2 2025, an estimated $120K.
  • Stelac Advisory Services first reported a position in Global X Genomics & Biotechnology ETF in Q4 2021 and held it in 14 quarters.
  • Stelac Advisory Services's Global X Genomics & Biotechnology ETF position peaked at $160K in Q3 2022.
  • 53 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2025.

Based on Stelac Advisory Services's 13F filing for Q2 2025, filed 12 Aug 2025.